Lineage Cell Therapeutics, Inc. (LCTX)
NYSEAMERICAN: LCTX · IEX Real-Time Price · USD
1.080
+0.020 (1.89%)
May 17, 2024, 4:00 PM EDT - Market closed

Lineage Cell Therapeutics Market Cap

Lineage Cell Therapeutics has a market cap or net worth of $203.90 million as of May 17, 2024. Its market cap has decreased by -15.01% in one year.

Market Cap
203.90M
Enterprise Value
163.53M
1-Year Change
-15.01%
Ranking
Category
Stock Price
$1.08

Market Cap Chart

Since December 1, 1998, Lineage Cell Therapeutics's market cap has increased from $147.40M to $203.90M, an increase of 38.33%. That is a compound annual growth rate of 1.28%.

History

DateMarket Cap% Change
May 17, 2024203.90M1.90%
May 16, 2024200.10M-2.77%
May 15, 2024205.80M4.79%
May 14, 2024196.40M-4.57%
May 13, 2024205.80M-6.84%
May 10, 2024220.90M-0.85%
May 9, 2024222.80M1.87%
May 8, 2024218.70M-7.95%
May 7, 2024237.60M-3.06%
May 6, 2024245.10M22.67%
May 3, 2024199.80M0.91%
May 2, 2024198.00M-7.04%
May 1, 2024213.00M3.65%
Apr 30, 2024205.50M-2.70%
Apr 29, 2024211.20M-1.72%
Apr 26, 2024214.90M2.68%
Apr 25, 2024209.30M0.92%
Apr 24, 2024207.40M-3.49%
Apr 23, 2024214.90M-
Apr 22, 2024214.90M-0.88%
Apr 19, 2024216.80M-4.16%
Apr 18, 2024226.20M-6.99%
Apr 17, 2024243.20M12.18%
Apr 16, 2024216.80M-8.02%
Apr 15, 2024235.70M-3.84%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Omeros 205.12M
Butterfly Network 204.58M
CervoMed 204.03M
Capricor Therapeutics 202.96M
AVITA Medical 202.79M
bluebird bio 200.41M
Delcath Systems 200.29M
Zevra Therapeutics 200.04M
Market Cap Rankings